COMP <GO>
OGN vs PBLS // FREE CASH FLOW YIELD
Organon & Co. (NYSE) VS. Parabilis Medicines Inc. (NASDAQ) • 15-METRIC TALLY: OGN 3
— PBLS 0
■ METRIC PARITY
LAST: $13.81 (+0.22%) • MKT CAP: $3.63B
fcf-yield
14.83%
LAST: $28.70 (+1.88%) • MKT CAP: $3.50B
fcf-yield
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OGN VS. PBLS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OGN | PBLS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.90% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 14.83% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 3.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -2.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.43% | 0.00% | +2.43 | OGN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.8 | 48.5 | +19.27 | OGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.63B | $3.50B | $126.6M | OGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OGN REV | PBLS REV | OGN GROSS % | PBLS GROSS % | OGN FCF | PBLS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.22B | $0 | 53.3% | — | $538.0M | — |
| FY 2024 | $6.40B | — | 58.0% | — | $764.0M | — |
| FY 2023 | $6.26B | — | — | — | $799.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OGN // BETA —
PBLS // BETA —